Pinpointing mutations in a relapsed children's cancer may lead to improved treatments
(Children's Hospital of Philadelphia) Researchers studying the pediatric cancer neuroblastoma have detailed how cancer-driving mutations evolve during chemotherapy, and they hope to exploit this knowledge to design better treatments for children.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Children | Health | Hospitals | International Medicine & Public Health | Neuroblastoma | Neurology | Pediatrics